Panel Discussion: How are Small to Mid-Size Biotechs Navigating the Current IVD Landscape?
Time: 2:00 pm
day: Conference Day Two - Track 2 - PM
Details:
- What impact on biomarker discovery have the new regulations had?
- Have they hindered clinical development?
- What do you need to see from the regulators?
- How can diagnostics companies assist development?
